发明授权
EP1305329B2 6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT 有权
6.ALPHA,9.ALPHA.二氟17.ALPHA .-(2- FURANYLCARBOXYL)OXY-11.BETA.羟基16.ALPHA.甲基-3-氧代雄甾-1,4-二烯 17硫代羧酸S-氟甲基酯作为抗炎药

  • 专利标题: 6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
  • 专利标题(中): 6.ALPHA,9.ALPHA.二氟17.ALPHA .-(2- FURANYLCARBOXYL)OXY-11.BETA.羟基16.ALPHA.甲基-3-氧代雄甾-1,4-二烯 17硫代羧酸S-氟甲基酯作为抗炎药
  • 申请号: EP01953272.0
    申请日: 2001-08-03
  • 公开(公告)号: EP1305329B2
    公开(公告)日: 2015-03-18
  • 发明人: BIGGADIKE, KeithCOOTE, Steven, JohnNICE, Rosalyn, Kay
  • 申请人: GLAXO GROUP LIMITED
  • 申请人地址: Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN GB
  • 专利权人: GLAXO GROUP LIMITED
  • 当前专利权人: GLAXO GROUP LIMITED
  • 当前专利权人地址: Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN GB
  • 代理机构: Florence, Julia Anne
  • 优先权: GB0019172 20000805; GB0108800 20010407
  • 国际公布: WO2002012265 20020214
  • 主分类号: C07J31/00
  • IPC分类号: C07J31/00 C07J17/00 A61K31/58 A61P5/44 A61P11/06 A61P11/08
6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
信息查询
0/0